Blog

T cells

Preparing for Cell and Gene Therapy 3.0

Patient data is mission-critical data — especially in cell and gene therapy.

In cell and gene therapy (CGT), the patient is the process is the product. Patient and/or donor data is an essential part of manufacturing and delivery, in unique and complex ways. It is also fundamental to patient safety and product and process knowledge, providing the opportunity to reduce risk and accelerate development.

Read More
September 19, 2019

The road ahead for #regenmed

This fall, it will be 15 years since regenerative medicine faced a crisis of funding and support in the United...

August 27, 2019

In September, here’s why it’s all about data management

Next month, my colleagues at Vineti and I will be speaking, writing, and presenting on a topic of critical importance...

August 22, 2019

September events! A Big Data webinar with Dr. Scott Burger, and a talk at CAR-TCR Summit

September marks the start of the autumn conference season in cell and gene therapy, and this fall I’m looking forward to...

August 13, 2019

Patient experiences – three inspiring stories

Every person working in cell therapies and gene therapies does so for the potential to improve patients’ lives. Emily Whitehead,...

August 8, 2019

Cell therapy and gene therapy news: updates from some of our biopharmaceutical partners

We’re always excited to support the innovation pursued by our biopharmaceutical partners as they work toward improved patient outcomes. Here...

July 22, 2019

Cell therapy and gene therapy — three summer reads that “get it”

In cell therapy, gene therapy, and personalized cancer vaccines, most media coverage understandably focuses on the medicine — the amazing...

July 10, 2019

Supply chain management readiness, Part 4: quality risk management

Note: this post is the last of a four-part series on supply chain planning for personalized therapies such as cell...

July 1, 2019

Vineti selected as Technology Pioneer by the World Economic Forum

Each year, the World Economic Forum welcomes leading early-stage companies from around the world into its Technology Pioneers community. Today, I’m both thrilled and...

June 30, 2019

Reasons for hope on the journey to personalized medicine “kaizen”

One of my very favorite writers, Siddhartha Mukherjee, published an article in The New Yorker this month on the importance of pursuing kaizen in balance...

June 26, 2019

Vineti joins the leadership of the Standards Coordinating Body

At Vineti, we’re pushing every day to help the field of advanced therapies — cell therapy, gene therapy, personalized cancer...

June 19, 2019

Cell therapy standards in action — a new case study on labeling

In cell therapy and gene therapy, in-process and final product labeling matters more to patient safety than ever before —...

June 12, 2019

ISCT 2019: data elements in the cell therapy value chain

I just got back from speaking at the International Society for Cell Therapy annual meeting, where the topic was next-gen data management....